BlackRock Institutional Trust’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $16M | Buy |
3,867,795
+460,419
| +14% | +$1.9M | ﹤0.01% | 2129 |
|
|
2016
Q3 | $27.6M | Buy |
3,407,376
+385,973
| +13% | +$3.13M | ﹤0.01% | 1658 |
|
|
2016
Q2 | $23.6M | Buy |
3,021,403
+136,258
| +5% | +$1.06M | ﹤0.01% | 1745 |
|
|
2016
Q1 | $22.3M | Sell |
2,885,145
-30,698
| -1% | -$237K | ﹤0.01% | 1753 |
|
|
2015
Q4 | $31.5M | Buy |
2,915,843
+89,770
| +3% | +$969K | 0.01% | 1551 |
|
|
2015
Q3 | $19.5M | Buy |
2,826,073
+109,962
| +4% | +$760K | ﹤0.01% | 1854 |
|
|
2015
Q2 | $24.1M | Sell |
2,716,111
-158,528
| -6% | -$1.4M | ﹤0.01% | 1795 |
|
|
2015
Q1 | $28.3M | Buy |
2,874,639
+343,036
| +14% | +$3.38M | ﹤0.01% | 1712 |
|
|
2014
Q4 | $31M | Sell |
2,531,603
-77,962
| -3% | -$955K | 0.01% | 1621 |
|
|
2014
Q3 | $26M | Sell |
2,609,565
-455,803
| -15% | -$4.55M | ﹤0.01% | 1717 |
|
|
2014
Q2 | $23.2M | Sell |
3,065,368
-82,828
| -3% | -$627K | ﹤0.01% | 1858 |
|
|
2014
Q1 | $10.4M | Buy |
3,148,196
+157,991
| +5% | +$520K | ﹤0.01% | 2399 |
|
|
2013
Q4 | $9.92M | Buy |
2,990,205
+285,301
| +11% | +$947K | ﹤0.01% | 2422 |
|
|
2013
Q3 | $8.17M | Buy |
2,704,904
+297,469
| +12% | +$898K | ﹤0.01% | 2482 |
|
|
2013
Q2 | $19.7M | Buy |
+2,407,435
| New | +$19.7M | ﹤0.01% | 1821 |
|